The incidence of risk factors for thrombophilia in young patients with venous thromboembolism and their monitoring in the anticoagulant clinic: a retrograde analysis of one-year outpatient treatment
Abstract
Background: Venous thromboembolisms (VTE) are presented as venous thrombosis and/ or pulmonary embolisms. When there are no risk factors found VTE is idiopatic. Methods: We analysed data from 1 January 2011 to 31 December 2011.Only patients under 50 years of age and with VTE were selected. One month after discontinuation of anticoagulant therapy they were tested for thrombophilia and we recieved the data. Results: 47 patients under 50 years of age with VTE were treated in this period. 21/47 (45 %) completed the therapy and were tested for thrombophilia. 3/21 patients had lupus anticoagulants, 5/21 had active protein C resistance and were heterozygous for factor V Leiden mutation. Conclusions: Screening for trombophila in patients with VTE generally does not influence the duration of antiocoagulant therapy. Tests make sense in younger patients, in unusual sites of VTE, with positive family history of VTE and recurrent VTE.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
